Literature DB >> 18415398

[New modes of opioid administration.].

H W Striebel1, R Schwagmeier, N Boerger.   

Abstract

In the last few years great interest has developed in new modes of opioid administration; oral transmucosal, transdermal, peripheral, and nasal administration.Oral transmucosal administration of fentanyl citrate (OTFC) has most often been used for premedication in children. Meanwhile, studies on the use of OTFC in cancer patients for postoperative pain management have also been published. While OTFC may have a limited role in postoperative pain management, it may prove very helpful in the management of incident and breakthrough cancer pain. Patient acceptance is high, and the onset of action is relatively rapid.Transdermal administration of fentanyl (TTS fentanyl) has been extensively examined, especially in postoperative patients. Patient acceptance is high, and TTS-fentanyl-related side-effects (e.g. mild erythema at the site of application) are minor. Application is performed at 72-h intervals. Kinetics are stable with repeated dosing, and serum concentrations approach steady state with the first dose. The slow rise/decline in fentanyl plasma concentration with patch application/removal makes it less well suited for postoperative pain management. However, TTS fentanyl seems to be a promising mode of opioid administration for cancer patients.-Recent papers have unequivocally demonstrated a peripheral antinociceptive effect oflocally applied opioids, especially in inflamed tissue. However, the results of clinical investigations are equivocal so far: about half the reports demonstrate an analgesic effect of peripherally administered opioids, and the other half, not.Intranasal administration was introduced for premedication in children, but benzodiazepines seem to be the better and safer choice. Nonetheless, intranasal opioids guarantee a rapid rise in opioid plasma concentrations as well as a rapid onset of pain relief. This mode of administration seems to be especially suitable for the treatment of acute pain syndromes, such as breakthrough cancer pain or incident pain. Patient acceptance is high, and no local problems were reported.

Entities:  

Year:  1993        PMID: 18415398     DOI: 10.1007/BF02530420

Source DB:  PubMed          Journal:  Schmerz        ISSN: 0932-433X            Impact factor:   1.107


  54 in total

1.  Postoperative pain relief--time to take our heads out of the sand?

Authors:  M Harmer
Journal:  Anaesthesia       Date:  1991-03       Impact factor: 6.955

2.  Oral transmucosal fentanyl citrate for the treatment of breakthrough cancer pain: a case report.

Authors:  M A Ashburn; P G Fine; T H Stanley
Journal:  Anesthesiology       Date:  1989-10       Impact factor: 7.892

3.  [Status of postoperative pain therapy in West Germany. Results of a representative survey].

Authors:  K A Lehmann; C Henn
Journal:  Anaesthesist       Date:  1987-08       Impact factor: 1.041

4.  Transdermal fentanyl for pain control in patients with cancer.

Authors:  Angela W Miser; Prem K Narang; Judith A Dothage; Robert C Young; William Sindelar; James S Miser
Journal:  Pain       Date:  1989-04       Impact factor: 6.961

5.  Peripheral antinociceptive effects of N-methyl morphine.

Authors:  T W Smith; P Buchan; D N Parsons; S Wilkinson
Journal:  Life Sci       Date:  1982 Sep 20-27       Impact factor: 5.037

6.  Double-blind comparison of oral transmucosal fentanyl citrate with oral meperidine, diazepam, and atropine as preanesthetic medication in children with congenital heart disease.

Authors:  M C Goldstein-Dresner; P J Davis; E Kretchman; R D Siewers; N Certo; D R Cook
Journal:  Anesthesiology       Date:  1991-01       Impact factor: 7.892

7.  The effects of oral transmucosal fentanyl citrate premedication on preoperative behavioral responses and gastric volume and acidity in children.

Authors:  T H Stanley; B C Leiman; N Rawal; M A Marcus; M van den Nieuwenhuyzen; A Walford; L H Cronau; N L Pace
Journal:  Anesth Analg       Date:  1989-09       Impact factor: 5.108

8.  Opioid analgesia at peripheral sites: a target for opioids released during stress and inflammation?

Authors:  J L Joris; R Dubner; K M Hargreaves
Journal:  Anesth Analg       Date:  1987-12       Impact factor: 5.108

9.  Oral transmucosal fentanyl citrate premedication in children.

Authors:  J B Streisand; T H Stanley; B Hague; H van Vreeswijk; G H Ho; N L Pace
Journal:  Anesth Analg       Date:  1989-07       Impact factor: 5.108

10.  Comparison of intravenous and intranasal sufentanil absorption and sedation.

Authors:  J H Helmers; H Noorduin; A Van Peer; L Van Leeuwen; W W Zuurmond
Journal:  Can J Anaesth       Date:  1989-09       Impact factor: 5.063

View more
  1 in total

1.  [The postoperative pain therapy].

Authors:  René Pschowski; Johann Motsch
Journal:  Wien Med Wochenschr       Date:  2008
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.